• Exchange: Berlin
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Life Science Equipment

QL1:GR

18.325 EUR 0.437 2.44%

As of 09:33:20 ET on 08/27/2014.

Snapshot for Quidel Corp (QL1)

Open: 18.260 Day's Range: 18.140 - 18.325 Volume: 0
Previous Close: 17.888 52wk Range: 13.300 - 23.083 1-Yr Rtn: -5.65%

Stock Chart for QL1

No chart data available.
  • QL1:GR 18.325
  • 1D
  • 1M
  • 1Y
17.888
Interactive QL1 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for QL1

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 172.6870
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) 0.1400
Est. PEG Ratio 10.6814
Market Cap (M EUR) 628.71
Shares Outstanding (M) 34.31
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/23/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for QL1

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for QL1

Quidel Corporation discovers, develops, manufactures, and markets rapid diagnostic products for point-of-care detection of human medical conditions and illnesses. The Company's products provide diagnoses for acute and chronic conditions in the areas of women's health and infectious diseases. Quidel's products are sold to professionals and to consumers.

Douglas C BryantPresident/CEORandall J StewardChief Financial Officer
Timothy T StenzelChief Scientific OfficerRobert Joseph BujarskiSenior VP:Bus Dev/Secy/Gen Cnsl
More Company Profile & Key Executives for QL1

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil